ArticleAnnals of surgical oncology2025
An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.
Taharam Fazal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.